D.R. Horton is tapping a startup’s AI zoning tool to build more homes
Portland, Oregon-based startup Prophetic has developed an AI-native platform for land acquisition and development analysis.
Merck bets on flu prevention with about $9.2 billion deal for Cidara Therapeutics
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.
Jefferies upgrades this retailer on emerging opportunity in beauty business
Jefferies forecasts shares of Gap adding 24% from here.
Fewer burritos, more bargains: Consumers flash holiday warning signs
In the coming week, some of the biggest names in retail, including Walmart, Target, Gap and Home Depot will report their latest earnings.
The question everyone in AI is asking: How long before a GPU depreciates?
With over $1 trillion in AI spending planned over the next five years, the useful lifespan of the infrastructure is a key issue for investors.
Alibaba cross-border arm plans AI subscriptions and stablecoin-like payments with JPMorgan
Alibaba plans to use “tokenization” of payments for cross-border transactions in its business-to-business arm.
Markets no longer view the December rate cut as a sure bet, with Fed officials casting doubts
Fed Chair Jerome Powell wasn’t kidding a couple weeks ago when he said a December rate cut wasn’t in the bag.
UK borrowing costs jump, stocks slide as speculation mounts over high-stakes budget
British government bond yields rose sharply on Friday morning.
Novo Nordisk’s leadership strategy tested as shareholders signal frustration ahead of vote on board revamp
Novo Nordisk has found itself in an increasingly chaotic situation as of late, with shares plunging and investor confidence waning.
Bet on Europe’s ‘GOTCHA’ stocks for global returns in 2026, UBS says
Strategists at UBS outlined their expectations of European stocks — and identified a number of companies with significant upside potential.